The Human Skin Blanching Assay for Topical Corticosteroid Bioavailability Assessment
The human skin blanching assay (often called the vasoconstrictor assay) has been used for nearly 30 years as a means of qualitatively assessing the topical availability and potency of corticosteroids. This bioassay uses the skin-whitening side effect of this class of drugs to estimate the rate and extent of corticosteroid diffusion to the dermal vasculature, the intensity of this whiteness correlating directly with the topical availability of the drug. This versatile bioassay may be applied in a number of test modes: to evaluate the topical potency of newly synthesized corticosteroid molecules, to assess the effects of the delivery vehicle formulation on the delivery of the drug to the skin, to assess the efficacy of penetration enhancers, or to rank the potency of commercial formulations for clinical and registration purposes. The latter has probably been the most widespread use of the assay, as it is now well established that incorporating identical concentrations of the same drug into two different topical vehicles (chemical equivalency) does not necessarily produce topically bioequivalent dosage forms. Various forms of the blanching assay have been used to compare drug release from ointments,1,2 creams, and gels,2,3 and for the comparison of generic formulations to trade-name “equivalents.”4–6 The major problem that arises with this data is that the diversity in experimental methodology practiced by the various researchers7–9 makes interstudy comparison of results difficult.
Unable to display preview. Download preview PDF.
- 11.Smith EW, Meyer E, Haigh JM, et al. The human skin blanching assay as an indicator of topical corticosteroid bioavailability and potency: an update. In: Bronaugh RL, Maibach HI, eds. Percutaneous Absorption. Vol. 2. New York: Marcel Dekker; 1989:443.Google Scholar
- 17.Raymond GP, Collins JP, Mailhot R. Triple corticosteroid integrated system in the treatment of psoriasis: a new approach to topical corticosteroid therapy. Curr Ther Res 1985;37:770–778.Google Scholar
- 19.Conner DP, Zamani K, Nix D, et al. Use of reflectance spectrometry in the corticosteroid skin blanching assay. Clin Pharmacol Ther. 1990;47:170.Google Scholar
- 20.Trikam DSK, Morton DJ. Development of an objective method for assessing topical corticosteroid efficacy. Cent African J Med. 1985;31:228–229.Google Scholar